These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 38797268)
21. Long noncoding TUG1 promotes angiogenesis of HUVECs in PE via regulating the miR-29a-3p/VEGFA and Ang2/Tie2 pathways. Liu Z; Guo N; Zhang XJ Microvasc Res; 2022 Jan; 139():104231. PubMed ID: 34352236 [TBL] [Abstract][Full Text] [Related]
22. Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis. Wang J; Li G; Wang Y; Tang S; Sun X; Feng X; Li Y; Bao G; Li P; Mao X; Wang M; Liu P Oncotarget; 2015 Dec; 6(42):44579-92. PubMed ID: 26625311 [TBL] [Abstract][Full Text] [Related]
23. The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1α in liver cancer cells. Fu C; An N; Liu J; A J; Zhang B; Liu M; Zhang Z; Fu L; Tian X; Wang D; Dong JT J Biol Chem; 2020 May; 295(20):7060-7074. PubMed ID: 32277050 [TBL] [Abstract][Full Text] [Related]
24. CREB3L4 promotes angiogenesis and tumor progression in gastric cancer through regulating VEGFA expression. Wang N; Chen Y; Shi C; Lin Z; Xie H Cancer Gene Ther; 2022 Feb; 29(2):241-252. PubMed ID: 33637885 [TBL] [Abstract][Full Text] [Related]
25. miR-493-5p Silenced by DNA Methylation Promotes Angiogenesis via Exosomes and VEGF-A-Mediated Intracellular Cross-Talk Between ESCC Cells and HUVECs. Xiao Z; Zhao J; Ji G; Song X; Xue X; Zhang W; Sha G; Zhou Y; Zhou J; Tian Z; Zhao X; Jiang N Int J Nanomedicine; 2024; 19():7165-7183. PubMed ID: 39050873 [TBL] [Abstract][Full Text] [Related]
26. The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer. Gong K; Jiao J; Xu C; Dong Y; Li D; He D; Zhao D; Yu J; Sun Y; Zhang W; Bai M; Duan Y J Nanobiotechnology; 2021 May; 19(1):165. PubMed ID: 34059068 [TBL] [Abstract][Full Text] [Related]
27. Knockdown of growth factor receptor bound protein 7 suppresses angiogenesis by inhibiting the secretion of vascular endothelial growth factor A in ovarian cancer cells. Xu Q; Liu Z; Zhu ZQ; Fan Y; Chen R; Xie XH; Cheng M Bioengineered; 2021 Dec; 12(2):12179-12190. PubMed ID: 34783299 [TBL] [Abstract][Full Text] [Related]
28. Exosomal LBH inhibits epithelial-mesenchymal transition and angiogenesis in nasopharyngeal carcinoma via downregulating VEGFA signaling. Wu A; Luo N; Xu Y; Du N; Li L; Liu Q Int J Biol Sci; 2022; 18(1):242-260. PubMed ID: 34975330 [TBL] [Abstract][Full Text] [Related]
29. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway. Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337 [TBL] [Abstract][Full Text] [Related]
30. MiR-590-5p inhibits colorectal cancer angiogenesis and metastasis by regulating nuclear factor 90/vascular endothelial growth factor A axis. Zhou Q; Zhu Y; Wei X; Zhou J; Chang L; Sui H; Han Y; Piao D; Sha R; Bai Y Cell Death Dis; 2016 Oct; 7(10):e2413. PubMed ID: 27735951 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma. Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438 [TBL] [Abstract][Full Text] [Related]
32. Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway. Zhong Z; Huang M; Lv M; He Y; Duan C; Zhang L; Chen J Cancer Lett; 2017 Sep; 403():305-317. PubMed ID: 28687357 [TBL] [Abstract][Full Text] [Related]
33. Serine/threonine-protein kinase STK24 induces tumorigenesis by regulating the STAT3/VEGFA signaling pathway. Lai S; Wang D; Sun W; Cao X J Biol Chem; 2023 Mar; 299(3):102961. PubMed ID: 36720310 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2-signal transducer and activator of transcription 3 pathway. Liu X; Gao X; Zhang W; Zhu T; Bi W; Zhang Y IUBMB Life; 2018 Jan; 70(1):81-91. PubMed ID: 29281186 [TBL] [Abstract][Full Text] [Related]
35. Roles of arrest-defective protein 1(225) and hypoxia-inducible factor 1alpha in tumor growth and metastasis. Lee MN; Lee SN; Kim SH; Kim B; Jung BK; Seo JH; Park JH; Choi JH; Yim SH; Lee MR; Park JG; Yoo JY; Kim JH; Lee ST; Kim HM; Ryeom S; Kim KW; Oh GT J Natl Cancer Inst; 2010 Mar; 102(6):426-42. PubMed ID: 20194889 [TBL] [Abstract][Full Text] [Related]
36. CTEN Inhibits Tumor Angiogenesis and Growth by Targeting VEGFA Through Down-Regulation of β-Catenin in Breast Cancer. Lu X; Zhou B; Cao M; Shao Q; Pan Y; Zhao T Technol Cancer Res Treat; 2021; 20():15330338211045506. PubMed ID: 34817293 [TBL] [Abstract][Full Text] [Related]
37. Circ-100290 Positively Regulates Angiogenesis Induced by Conditioned Medium of Human Amnion-Derived Mesenchymal Stem Cells Through miR-449a/eNOS and miR-449a/VEGFA Axes. Tang Z; Wu X; Hu L; Xiao Y; Tan J; Zuo S; Shen M; Yuan X Int J Biol Sci; 2020; 16(12):2131-2144. PubMed ID: 32549760 [TBL] [Abstract][Full Text] [Related]
38. AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo. Zhang PC; Liu X; Li MM; Ma YY; Sun HT; Tian XY; Wang Y; Liu M; Fu LS; Wang YF; Chen HY; Liu Z Biochem Pharmacol; 2020 Feb; 172():113771. PubMed ID: 31863779 [TBL] [Abstract][Full Text] [Related]
39. Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway. Leng K; Xu Y; Kang P; Qin W; Cai H; Wang H; Ji D; Jiang X; Li J; Li Z; Huang L; Zhong X; Sun X; Wang Z; Cui Y Cell Death Dis; 2019 Mar; 10(4):262. PubMed ID: 30886152 [TBL] [Abstract][Full Text] [Related]
40. miR-200b and cancer/testis antigen CAGE form a feedback loop to regulate the invasion and tumorigenic and angiogenic responses of a cancer cell line to microtubule-targeting drugs. Kim Y; Park D; Kim H; Choi M; Lee H; Lee YS; Choe J; Kim YM; Jeoung D J Biol Chem; 2013 Dec; 288(51):36502-18. PubMed ID: 24174534 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]